We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 51

Pfizer v. Novopharm
  • Gowling WLG
  • Canada
  • June 24 2009

The Federal Court granted prohibition in respect of a patent claiming the use of sildenafil for the treatment of erectile dysfunction by oral administration


Celgene v. Canada
  • Gowling WLG
  • Canada
  • June 24 2009

Celgene is the current owner of several patents relating to thalidomide


Apotex v. Pfizer
  • Gowling WLG
  • Canada
  • March 4 2009

The Court of Appeal dismissed the generic company's appeal and upheld the decision of the trial judge prohibiting Apotex entering the market until the expiry of the patent


Solvay v. Canada (Minister of Health)
  • Gowling WLG
  • Canada
  • March 4 2009

The Court upheld the decision of the Minister refusing to list a patent on the Patent Register


G.D. Searle v. Canada (Minister of Health)
  • Gowling WLG
  • Canada
  • March 4 2009

The Minister of Health removed a patent from the Patent Register on the basis that it was ineligible for listing


Novopharm v. Eli Lilly
  • Gowling WLG
  • Canada
  • March 4 2009

The Court dismissed a motion by the Canadian Generic Pharmaceutical Association (CGPA) requesting leave to intervene in Novopharm's appeal of a decision of the Federal Court


Apotex & Novopharm v. Wellcome; interlocutory motion to amend pleadings
  • Gowling WLG
  • Canada
  • November 2 2009

The Trial Division upheld the decision of the Prothonotary to allow GSK to amend its pleadings revising the quantum of damages sought in the proceeding


Eli Lilly v. Novopharm; merits of an infringement proceeding
  • Gowling WLG
  • Canada
  • November 2 2009

After a trial on the merits, the Court found that the patent at issue was invalid as it is not a valid selection patent


Eli Lilly v. Apotex
  • Gowling WLG
  • Canada
  • May 4 2009

The Court dismissed the application for prohibition on the basis that the allegations of anticipation, obviousness, claims broader and Gillette defence are justified


Eli Lilly v. Apotex
  • Gowling WLG
  • Canada
  • May 4 2009

In the underlying decision on the merits, the Federal Court dismissed the application on the basis that the allegation as to a lack of sound prediction because the patent lacks adequate disclosure was justified